AVEO Pharmaceuticals, Inc. · Cambridge, MA United States (NASDAQ: AVEO)
| 75 Sidney St. | Phone: 617-299-5000 |
| Cambridge, MA | Fax: 617-995-4995 |
| 02139 | |
| United States | 
Map This Company |
AVEO Pharmaceuticals, Inc. Rankings
Company Description
AVEO Pharmaceuticals' models don't pout, strut, or even turn heads -- unless you're a cancer drug researcher. The biotech firm develops cancer models to uncover how genes mutate into tumors and how tumors progress through additional mutations. AVEO then builds genetic profiles of such tumors and applies them to antibody (protein) drug candidates in preclinical and clinical development to help predict actual human responses. In addition to its own pipeline of potential drugs, AVEO has partnered with other pharmaceutical developers to apply its Human Response Platform to their drug candidates. The company completed an IPO in 2010.
AVEO Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: AVEO Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 147 |
Executives
48 executives listed for AVEO Pharmaceuticals, Inc.'s Cambridge, MA location.
| Chairman | Anthony Evnin | |
|---|---|---|
| President, CEO, and Director | Tuan Ha-Ngoc | |
| CFO | David Johnston |